The Psychedelic Drug Development Digital Summit deals with synthetic and natural psychoactive substances to treat addiction, depression, anxiety and other life debilitating psychiatric conditions.
The Psychedelic Drug Development Digital Summit covers topics such as:
- Clinical best practice, trial set up and scale, investigating novel indications and dose escalation to demonstrate safety and efficacy
- The fundamental biology of psychedelic drugs and how to apply this knowledge to therapeutic design
- Stigma, education, and policy change to deliver life-changing psychedelic therapies
